TY - JOUR
T1 - Role of α7-nicotinic acetylcholine receptors in tetanic stimulation-induced γ oscillations in rat hippocampal slices
AU - Song, Chuanzhe
AU - Murray, Teresa A.
AU - Kimura, Ryoichi
AU - Wakui, Makoto
AU - Ellsworth, Kevin
AU - Javedan, Sam P.
AU - Marxer-Miller, Syndia
AU - Lukas, Ronald J.
AU - Wu, Jie
N1 - Funding Information:
This study was funded by the Sandra Solheim Aiken Fund for Epilepsy and the Women's Board of the Barrow Neurological Institute (J Wu). Authors thank the BNI Scientific Enrichment Research Program for Students (SERPS) for the partial support of this study (CZ Song). TA Murray was supported by a fellowship from the National Science Foundation Integrative Graduate Education and Research Training (IGERT) program. Support for the work conducted in the Charlotte and Harold Simensky Neurochemistry of Alzheimer's Disease Laboratory was provided by National Institutes of Health grant NS040417, and the Roberta and Gloria Wallace Foundation.
PY - 2005/5
Y1 - 2005/5
N2 - Hippocampal γ oscillations, as a form of neuronal network synchronization, are speculated to be associated with learning, memory and attention. Nicotinic acetylcholine receptor α7 subtypes (α7-nAChRs) are highly expressed in hippocampal neurons and play important roles in modulating neuronal function, synaptic plasticity, learning and memory. However, little is known about the role of α7-nAChRs in hippocampal γ oscillations. Here, we examined the effects of selective α7- and non-α7-nAChR antagonists on tetanic γ oscillations in rat hippocampal slices. We found that brief tetanic stimulation-induced γ oscillations (30-80 Hz) and pharmacological blockade of α7-nAChRs using the relatively selective α7-nAChR antagonists, methyllycaconitine (10 or 100 nM) or α-bungarotoxin (10 nM), significantly reduced the frequency spectrum power, the number of spikes, and burst duration of evoked γ oscillations. Neither mecamylamine nor dihydro-β-erythroidine, which are selective antagonists of non-α7-nAChRs, demonstrated significant effects on tetanic γ oscillations. Nicotine exposure promotes hippocampal γ oscillations in a methyllycaconitine-sensitive manner. It is concluded that α7-nAChRs in hippocampal slices play important roles in regulation of γ oscillations, thus potentially helping to explain roles of nAChRs in cognitive functions such as learning, memory and attention.
AB - Hippocampal γ oscillations, as a form of neuronal network synchronization, are speculated to be associated with learning, memory and attention. Nicotinic acetylcholine receptor α7 subtypes (α7-nAChRs) are highly expressed in hippocampal neurons and play important roles in modulating neuronal function, synaptic plasticity, learning and memory. However, little is known about the role of α7-nAChRs in hippocampal γ oscillations. Here, we examined the effects of selective α7- and non-α7-nAChR antagonists on tetanic γ oscillations in rat hippocampal slices. We found that brief tetanic stimulation-induced γ oscillations (30-80 Hz) and pharmacological blockade of α7-nAChRs using the relatively selective α7-nAChR antagonists, methyllycaconitine (10 or 100 nM) or α-bungarotoxin (10 nM), significantly reduced the frequency spectrum power, the number of spikes, and burst duration of evoked γ oscillations. Neither mecamylamine nor dihydro-β-erythroidine, which are selective antagonists of non-α7-nAChRs, demonstrated significant effects on tetanic γ oscillations. Nicotine exposure promotes hippocampal γ oscillations in a methyllycaconitine-sensitive manner. It is concluded that α7-nAChRs in hippocampal slices play important roles in regulation of γ oscillations, thus potentially helping to explain roles of nAChRs in cognitive functions such as learning, memory and attention.
KW - 40 Hz oscillation
KW - Cognitive function
KW - Neuronal network synchronization
KW - Nicotine
UR - http://www.scopus.com/inward/record.url?scp=16844365215&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=16844365215&partnerID=8YFLogxK
U2 - 10.1016/j.neuropharm.2005.01.003
DO - 10.1016/j.neuropharm.2005.01.003
M3 - Article
C2 - 15829257
AN - SCOPUS:16844365215
SN - 0028-3908
VL - 48
SP - 869
EP - 880
JO - Neuropharmacology
JF - Neuropharmacology
IS - 6
ER -